IN VIVO PROTEIN REPLACEMENT PLATFORM
Dead / Abandoned — Abandoned — failure to respond (as of 05 Jan 2018)
What this means for you
This application is over — abandoned 07 Dec 2017. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86919841
- Mark type
- Stylized text
- Filed
- 25 Feb 2016
- Abandoned
- 07 Dec 2017
- Attorney of record
- Tali L. Alban
Goods and services
- Class 042 — Scientific and technological services: Medical and scientific research and development and consultation related thereto, all in the field of pharmaceutical preparations and drugs; conducting clinical trials for others in the field of pharmaceutical preparations and drugs
Owner
- SANGAMO THERAPEUTICS, LNC., RICHMOND, CA, US
- Sangamo BioSciences, Inc., Richmond, CA, US
Prosecution history
- 05 Jan 2018 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 05 Jan 2018 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 07 Jun 2017 — NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
- 06 Jun 2017 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 06 Jun 2017 — NON-FINAL ACTION E-MAILED
- 06 Jun 2017 — NON-FINAL ACTION WRITTEN
- 06 Jun 2017 — USE AMENDMENT ACCEPTED
- 24 May 2017 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 16 May 2017 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 15 May 2017 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 15 May 2017 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 16 May 2017 — AMENDMENT TO USE PROCESSING COMPLETE
- 16 May 2017 — USE AMENDMENT FILED
- 15 May 2017 — TEAS AMENDMENT OF USE RECEIVED
- 19 Apr 2017 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP